The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients

被引:81
作者
Aldawood A. [1 ]
Arabi Y. [1 ]
Aljumah A. [2 ]
Alsaadi A. [1 ]
Rishu A. [1 ]
Aldorzi H. [1 ]
Alqahtani S. [1 ]
Alsultan M. [1 ]
Felemban A. [3 ]
机构
[1] Intensive Care Department, King Saud Bin Abdulaziz University for Health Science-King Abdulaziz Medical City, Riyadh
[2] Hepatobiliary Science Department, King Saud Bin Abdulaziz University for Health Science-King Abdulaziz Medical City, Riyadh
[3] Obstetric and Gynecology Department, King Saud Bin Abdulaziz University for Health Science-King Abdulaziz Medical City, Riyadh
关键词
Liver Cirrhosis; International Normalize Ratio; Deep Vein Thrombosis; Cirrhotic Patient; Mechanical Prophylaxis;
D O I
10.1186/1477-9560-9-1
中图分类号
学科分类号
摘要
Background: Cirrhotic patients are characterized by a decreased synthesis of coagulation and anticoagulation factors. The coagulopathy of cirrhotic patients is considered to be auto-anticoagulation. Our aim was to determine the incidence and predictors of venous thromboembolism (VTE) and examine the practice of deep venous thrombosis (DVT) prophylaxis among hospitalized cirrhotic patients.Methods: A retrospective cohort study was performed in a tertiary teaching hospital. We included all adult patients admitted to the hospital with a diagnosis of liver cirrhosis from January 1, 2009 to December 31, 2009. We grouped our cohort patients in two groups, cirrhotic patients without VTE and cirrhotic with VTE.Results: Over one year, we included 226 cirrhotic patients, and the characteristics of both groups were similar regarding their clinical and laboratory parameters and their outcomes. Six patients (2.7%) developed VTE, and all of the VTEs were DVT. Hepatitis C was the most common (51%) underlying cause of liver cirrhosis, followed by hepatitis B (22%); 76% of the cirrhotic patients received neither pharmacological nor mechanical DVT prophylaxis.Conclusion: Cirrhotic patients are at risk for developing VTE. The utilization of DVT prophylaxis was suboptimal. © 2011 Aldawood et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 23 条
[1]  
Mansoor I., Experience of liver disease at a University Hospital in Western Saudi Arabia, Saudi Med J, 23, pp. 1070-1073, (2002)
[2]  
Madani T.A., Hepatitis C virus infections reported over 11 years of surveillance in Saudi Arabia, Trans R Soc Trop Med Hyg, 103, pp. 132-136, (2009)
[3]  
Armstrong G.L., Wasley A., Simard E.P., McQuillan G.M., Kuhnert W.L., Alter M.J., The prevalence of hepatitis C virus infection in the United States, 1999 through 2002, Ann Intern Med, 144, pp. 705-714, (2006)
[4]  
El Beltagy K.E., Al Balawi I.A., Almuneef M., Memish Z.A., Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia, Int J Infect Dis, 12, pp. 495-499, (2008)
[5]  
Amitrano L., Brancaccio V., Guardascione M.A., Margaglione M., Iannaccone L., D'Andrea G., Marmo R., Ames P.R., Balzano A., Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis, Hepatology, 31, pp. 345-348, (2000)
[6]  
Senzolo M., Burra P., Cholongitas E., Burroughs A.K., New insights into the coagulopathy of liver disease and liver transplantation, World J Gastroenterol, 12, pp. 7725-7736, (2006)
[7]  
Gulley D., Teal E., Suvannasankha A., Chalasani N., Liangpunsakul S., Deep vein thrombosis and pulmonary embolism in cirrhosis patients, Dig Dis Sci, 53, pp. 3012-3017, (2008)
[8]  
Tripodi A., Primignani M., Mannucci P.M., Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged, Intern Emerg Med, 5, pp. 7-12
[9]  
Sogaard K.K., Horvath-Puho E., Gronbaek H., Jepsen P., Vilstrup H., Sorensen H.T., Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study, Am J Gastroenterol, 104, pp. 96-101, (2009)
[10]  
Tripodi A., Primignani M., Chantarangkul V., Dell'Era A., Clerici M., de Franchis R., Colombo M., Mannucci P.M., An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis, Gastroenterology, 137, pp. 2105-2111, (2009)